annual cash & cash equivalents:
$430.61M+$411.40M(+2142.15%)Summary
- As of today (September 15, 2025), JANX annual cash & cash equivalents is $430.61 million, with the most recent change of +$411.40 million (+2142.15%) on December 31, 2024.
- During the last 3 years, JANX annual cash & cash equivalents has risen by +$395.02 million (+1110.18%).
- JANX annual cash & cash equivalents is now at all-time high.
Performance
JANX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$996.01M-$18.14M(-1.79%)Summary
- As of today (September 15, 2025), JANX quarterly cash & cash equivalents is $996.01 million, with the most recent change of -$18.14 million (-1.79%) on June 30, 2025.
- Over the past year, JANX quarterly cash & cash equivalents has increased by +$349.72 million (+54.11%).
- JANX quarterly cash & cash equivalents is now -2.84% below its all-time high of $1.03 billion, reached on December 31, 2024.
Performance
JANX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
JANX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2142.2% | +54.1% |
| 3 y3 years | +1110.2% | +181.1% |
| 5 y5 years | +10000.0% | - |
JANX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2142.2% | -2.8% | +228.4% |
| 5 y | 5-year | at high | >+9999.0% | -2.8% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -2.8% | >+9999.0% |
JANX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $996.01M(-1.8%) |
| Mar 2025 | - | $1.01B(-1.1%) |
| Dec 2024 | $430.61M(+2142.2%) | $1.03B(+55.8%) |
| Sep 2024 | - | $658.03M(+1.8%) |
| Jun 2024 | - | $646.29M(-0.8%) |
| Mar 2024 | - | $651.76M(+89.5%) |
| Dec 2023 | $19.20M(-62.7%) | $344.03M(-1.6%) |
| Sep 2023 | - | $349.71M(+15.3%) |
| Jun 2023 | - | $303.29M(-4.3%) |
| Mar 2023 | - | $316.88M(-3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $51.43M(+44.5%) | $327.02M(-3.5%) |
| Sep 2022 | - | $338.76M(-4.4%) |
| Jun 2022 | - | $354.30M(-1.9%) |
| Mar 2022 | - | $361.20M(-3.7%) |
| Dec 2021 | $35.58M(+355.4%) | $374.96M(-3.2%) |
| Sep 2021 | - | $387.51M(-1.7%) |
| Jun 2021 | - | $394.19M(+457.0%) |
| Mar 2021 | - | $70.77M(+805.8%) |
| Dec 2020 | $7.81M(+1087.4%) | $7.81M |
| Dec 2019 | $658.00K | - |
FAQ
- What is Janux Therapeutics, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Janux Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Janux Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of JANX is $430.61M
What is the all time high annual cash & cash equivalents for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high annual cash & cash equivalents is $430.61M
What is Janux Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, JANX annual cash & cash equivalents has changed by +$411.40M (+2142.15%)
What is Janux Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of JANX is $996.01M
What is the all time high quarterly cash & cash equivalents for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $1.03B
What is Janux Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, JANX quarterly cash & cash equivalents has changed by +$349.72M (+54.11%)